Electron activated dissociation

EAD is a groundbreaking approach for tandem mass spectrometry (MS/MS) applications

The Goldilocks principle of MS/MS

There are various MS/MS scan types for qualitative studies, but the most widely used is the product ion scan. This involves selecting precursor ions based on their mass, fragmenting them, and analyzing the resulting product ions. This process uses two stages of mass filtering with a fragmentation event in between. The masses and mass differences of the product ions help determine the structure or sequence of the original molecule, and the energy required for fragmentation reveals the nature of specific chemical bonds.

For MS/MS to be effective, fragmentation must be interpretable and reproducible. The energy transferred must be "just right"—sufficient to produce diagnostic product ions without obliterating the parent molecule. Even with the right energy, fragmentation can be insufficient, leaving gaps in the spectrum or missing key diagnostic ions. Important side chains and modifications might be cleaved off, leaving no indication of their location.

Various mechanisms have been used for fragmenting ions, including photons, electrons, atoms, molecules, and solid surfaces. The most common techniques use atoms, molecules, or electrons to impart energy for fragmentation.

The challenges of identification and characterization of biomolecules using MS/MS

While MS/MS has evolved into one of the most valuable analytical tools available to modern scientists, most MS/MS applications today use collision-induced dissociation (CID) to induce fragmentation. CID forms the underlying framework supporting most quantitative assays and is responsible for the identification and structural elucidation of countless compounds. However, like any approach, CID has its limitations. These limitations manifest as insufficient fragmentation of specific molecule classes, sizes, and chemistries, which can inhibit their characterization or selective quantitation. Consequently, there is a clear need for improved fragmentation mechanisms to address the shortcomings of CID.

When CID is not enough

Electron-based fragmentation mechanisms can address many of the shortcomings of CID by providing enhanced qualitative data, significantly extending the capabilities of MS/MS for structural elucidation. However, most commercially available electron-based fragmentation devices support either small molecule analysis or large molecule analysis, but not both. Electron transfer dissociation (ETD) and electron capture dissociation (ECD) require multiply charged precursor ions that capture low-energy electrons to induce fragmentation. Conversely, electron impact excitation of ions from organics (EIEIO) and other higher-energy electron fragmentation techniques fragment singly charged ions.

In cases where both CID and ETD are available, a third fragmentation technique, such as ultraviolet photodissociation (UVPD), is often used to fill the void. For simplicity and general applicability, an ideal electron-based fragmentation device would enable a range of EAD electron energies and eliminate the need for a reagent, as required in ETD.

What is EAD?

Electron-based fragmentation has been demonstrated to provide vital information essential for complete molecule identification and characterization. Its utility extends beyond CID, offering new and crucial insights even for traditionally difficult compounds. EAD encompasses a range of electron-based fragmentation mechanisms that vary by the kinetic energy of the irradiating electron beam and the charge states of the precursor ions dissociated. The ZenoTOF systems’ tunable EAD cell can deliver this range of kinetic energies and modify the reaction time according to charge, extending the approach's utility for both small (singly charged) and large (multiply charged) molecules.

Because EAD fragmentation is both fast and highly sensitive, it enables the structural elucidation of low-level compounds and variants, even during fast chromatographic separations. Workflows that traditionally use CID are amenable to EAD, such as in-depth analysis of complex biological mixtures, with EAD now providing new information that can clarify molecular structures.

Continual investments in developing MS/MS technologies are central to delivering tools and workflows that enable the characterization of an increasingly comprehensive suite of compound classes, molecular structures, and sample types. The new information that EAD provides allows scientists to make faster, more informed decisions, accelerating research and development and improving productivity for routine analytical applications.

EAD fragmentation in action for small molecules

Research and development labs continuously face challenges in characterizing small molecules. While CID is typically the first choice for MS/MS experiments, it can sometimes result in a puzzling absence of information when it is most needed. CID can produce limited or non-selective fragmentation, leading to inconclusive spectra and subpar quantitative assays. Small molecules, such as pesticides, metabolites, or lipids, can be extremely diverse in size, polarity, and solubility, further complicating the issue. This problem is often compounded by sensitivity challenges.

Events and webinars

Small molecules

Resources

Small molecules

EAD fragmentation in action for large molecules

Proteins exhibit a rich assortment of varying structures and modifications, often existing as extremely complex and heterogeneous mixtures within biological fluids. Consequently, acquiring MS/MS data is imperative for their characterization. While CID has been extensively used to determine the structure and sequence of large biomolecules, often after enzymatic digestion, full characterization of biomolecules, such as antibodies, antibody-drug conjugates, and viral vectors and their modifications, can be challenging or even impossible using CID alone.

EAD can provide a more complete picture. With EAD, fragmentation of large, multiply charged precursor ions is induced by the capture of lower-energy electrons, producing different fragment ions than those typically observed with CID. For example, in peptide fragmentation, CID typically produces "b" and "y" ions, while EAD produces "c" and "z" ions. These ions enable sequencing of the peptide amino acid backbone by examining the mass differences between sequential ions within a series, while keeping modifications intact, thus enabling in-depth characterization of post-translational modifications (PTM).

Resources

Large molecules

Workflow related components

ZenoTOF 8600 system

Extraordinary discoveries demand extraordinary proof. The SCIEX ZenoTOF 8600 system combines proven technology from our most sensitive triple quad with that of our most versatile Zeno trap-enabled QTOF. Delivering up to 10x improvements in sensitivity* means achieving lower limits of quantitation and enabling enhanced performance across a multitude of accurate mass workflows.

* Compared to the ZenoTOF 7600+ system

Learn more
SCIEX 7600+ system

Continuing the (r)evolution and taking biology beyond the ID numbers. Built off the ZenoTOF 7600 system and engineered with added specificity thanks to the scanning quadrupole dimension, the ZenoTOF 7600+ system delivers enhanced speed, depth, and certainty in quantitative measurements. Enabled with both ZenoSWATH DIA and ZT Scan DIA, the ZenoTOF 7600+ system is Ideal for high-throughput workflows and those with low sample volumes.

Learn more
Accurate MS with ZenoTOF 7600 system

Get qualitative flexibility combined with quantitative power. The ZenoTOF 7600 system represents a crucial step change in MS/MS technology with electron activated dissociation and provides a new level of power for characterizing the lipidome.

Learn more
ExionLC AE system

Discover reproducibility, reliability and carryover performance to match your quantitative workflows. Experience dependability you can count on from injection to injection and batch after batch.

Learn more
SCIEX OS software

Unleash the analytical power of a next-generation software platform for data acquisition and processing.

Learn more
Service

Keep your instruments performing at their peak with multiple options for response time, repair coverage and maintenance.

Learn more
Course Catalog

You can browse, filter, or search our extensive list of training offerings. Choose from over 100 self-paced eLearnings or search for an instructor-led course near you. Once you select the course you want, you will be directed to SCIEX Now Learning Hub for enrollment (login required).

Learn more

Biomedical and omics applications

Proteomics

Explore the depth and complexity of the proteome with modern, sophisticated approaches. Accelerate your understanding of biology with streamlined data acquisition, processing and interpretation solutions that can be applied to a single sample or on an industrial scale across large cohorts.

Learn more

Metabolomics

Make metabolomics data processing and interpretation easier. Achieve fast, confident insights with SCIEX solutions, whether you are investigating biological systems to discover and characterize new disease biomarkers or highlighting new targets for drug design.

Learn more

Lipidomics

Simplify lipidomics approaches and accelerate your research. Discover, identify and quantify thousands of lipids with confidence. Overcome the challenges of diverse lipid classes and molecular compounds with enhanced selectivity and powerful, time-saving solutions.

Learn more

SCIEX Omics community

Chat with your peers about how to get the most out of your proteomics, metabolomics and lipidomics studies.

Visit now

Pharma/Biopharma applications

Peptide mapping analysis

Address the need for complete sequence coverage, comprehensive determination of PTMs and reliable high-throughput monitoring assays with LC-MS solutions designed to address the challenges of peptide mapping at all stages of the therapeutic development pipeline.

Learn more

Middle-down analysis

Middle-down  mass analysis can be used as a screening tool for candidate developability, identity and quality. This approach addresses the need for fast and intuitive characterization of therapeutic proteins in early development to not only ensure drug efficacy and safety, but to quickly distinguish post-translational modifications (PTMs) and drug conjugation sites.

Learn more

Viral vector characterization

Optimize your processes with solutions that overcome the analytical challenges of viral vector-based drugs.

Learn more

Lipid nanoparticle and non-viral carriers

Expand the possibilities of drug delivery with innovative analytical solutions for lipid raw materials, lipid nanoparticles (LNPs), and other non-viral carriers.

Learn more

Let's connect

Stay up-to-date with omics conversations on LinkedIn and X